The list of diseases and conditions complicated by obesity is a long one; it includes heart disease, cancer, diabetes and impaired wound healing, as well as skin infections. It is not always clear, however, in what way this ...
Researchers at MIT, Brigham and Women's Hospital, and Harvard Medical School have developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss and affects people of all ages, including ...
May 9, 2024
0
153
Currently, most therapies for allergic diseases require lifelong treatment. Allergic reactions, characterized by ongoing (type 2) inflammation in response to chronic antigen exposure, underlie many chronic diseases in humans, ...
Apr 30, 2024
0
9
Scientists at Harvard Medical School have shown for the first time that a common skin bacterium—Staphylococcus aureus—can cause itch by acting directly on nerve cells.
Nov 22, 2023
0
60
Up to 15% of children and 5% of adults are affected by the chronic inflammatory skin disease atopic dermatitis. Despite advanced therapy measures, the severe itching and eczema, especially on the elbows or knees, cause great ...
Sep 29, 2023
1
30
A new Nature Immunology study led by University of Pittsburgh and National Institutes of Health researchers sheds light on how a rare type of helper T cell, called Th9, can drive allergic disease, suggesting new precision ...
May 3, 2023
0
42
Researchers at the Universities of Bonn and Singapore have discovered a new intracellular "smoke detector." The sensor warns of damage to the mitochondria—the microscopic power plants that supply the cell with energy. If ...
Mar 21, 2023
0
50
Patients with severe eczema who were treated with the drug dupilumab experienced a reduction in symptoms and improved quality of life, according to a meta-analysis of several clinical trials published in JAMA Dermatology.
Mar 2, 2023
0
94
A weekly dose of dupilumab, a monoclonal antibody, led to a reduction of symptoms and tissue improvement in young adults and adolescents with eosinophilic esophagitis (EoE), according to a new study published in the New England ...
Dec 22, 2022
0
25
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal antibody therapy—showed promising results both while taking the drug and up ...
Dec 9, 2022
1
70
